Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to 0.15%.

  • Mirum Pharmaceuticals' Return on Invested Capital rose 2700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.37% for FY2024, which is 1900.0% up from last year.
  • Mirum Pharmaceuticals' Return on Invested Capital amounted to 0.15% in Q3 2025, which was up 2700.0% from 0.24% recorded in Q2 2025.
  • Mirum Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.15% during Q3 2025, with a 5-year trough of 2.12% in Q3 2021.
  • In the last 5 years, Mirum Pharmaceuticals' Return on Invested Capital had a median value of 0.8% in 2022 and averaged 0.83%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first crashed by -12200bps in 2021, then soared by 12500bps in 2022.
  • Mirum Pharmaceuticals' Return on Invested Capital (Quarter) stood at 1.93% in 2021, then surged by 59bps to 0.8% in 2022, then surged by 47bps to 0.42% in 2023, then increased by 9bps to 0.39% in 2024, then surged by 60bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.24% for Q2 2025, and 0.34% during Q1 2025.